UNICHEM LABORATORIES LTD (UNICHEMLAB) financials

UNICHEM LABORATORIES LTD (UNICHEMLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Unichem Laboratories Ltd is involved in pharmaceuticalsin Generics, APIs and Contract Manufacturing (CMO) areas.[1]

Market Cap: ₹3,595Cr.
Current Price: ₹511
ROE: -0.61%
ROCE: -0.13%
Book Value: ₹373
Dividend Yield: 0.00%
52W High / Low: ₹687/278

In Jun 2026, UNICHEM LABORATORIES LTD (UNICHEMLAB) reported sales ₹366.27 Cr and net profit ₹5.53 Cr.

Annual TTM: sales ₹1,394 Cr, net profit ₹166 Cr.

Shareholding: Promoters 70.22% (Sep 2026), FIIs 2.70% (Sep 2026), DIIs 9.40% (Sep 2026), Public 17.67% (Sep 2026), No. of Shareholders 26,164% (Sep 2026).

UNICHEMLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	436.88	447.83	461.24	384.25	356.90	314.90	356.24	366.27
Expenses	372.38	373.62	386.26	358.51	349.20	313.51	343.75	345.63
Operating Profit	64.50	74.21	74.98	25.74	7.70	1.39	12.49	20.64
OPM %	14.76%	16.57%	16.26%	6.70%	2.16%	0.44%	3.51%	5.64%
Other Income	7.08	18.93	10.05	4.25	-11.74	290.55	9.86	16.72
Interest	1.82	2.89	1.53	1.93	3.68	2.10	4.09	1.29
Depreciation	26.39	28.45	27.47	29.93	30.11	30.02	28.97	28.69
Profit before tax	43.37	61.80	56.03	-1.87	-37.83	259.82	-10.71	7.38
Tax %	0.00%	24.13%	8.58%	-1.07%	5.55%	16.82%	43.70%	25.07%
Net Profit	43.37	46.89	51.22	-1.85	-39.93	216.11	-15.39	5.53
EPS in Rs	6.16	6.66	7.27	-0.26	-5.67	30.69	-2.19	0.79
Raw PDF	—	—	—	—	—	—	—	—

UNICHEMLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	904	1,124	943	1,072	1,442	1,736	1,412	1,394
Expenses	994	1,028	986	1,165	1,391	1,482	1,359	1,352
Operating Profit	-89	95	-43	-93	51	254	53	42
OPM %	-10%	8%	-4.6%	-9%	3.5%	15%	3.7%	3.0%
Other Income	98	47	42	-71	-27	45	287	305
Interest	1	1	2	9	10	8	12	11
Depreciation	71	76	83	106	105	108	119	118
Profit before tax	-64	66	-87	-279	-92	183	209	219
Tax %	-12%	18%	-36%	7%	0%	11%	24%	—
Net Profit	-56	54	-55	-300	-92	163	159	166
EPS in Rs	-8.00	7.68	-7.87	-42.57	-13.09	23.15	22.57	23.62
Dividend Payout %	-50%	52%	-51%	-9%	0%	0%	0%	—

UNICHEMLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	14	14	14	14	14	14	14	14
Reserves	2,718	2,633	2,683	2,658	2,370	2,281	2,446	2,613
Borrowings	0	17	1	132	108	70	123	64
Other Liabilities	298	361	420	318	394	477	527	401
Total Liabilities	3,030	3,025	3,119	3,122	2,886	2,842	3,109	3,092
Fixed Assets	789	829	850	963	1,236	1,165	1,275	1,189
CWIP	90	331	568	494	148	122	31	100
Investments	1,042	668	520	390	41	44	46	47
Other Assets	1,109	1,197	1,181	1,275	1,462	1,510	1,758	1,755
Total Assets	3,030	3,025	3,119	3,122	2,886	2,842	3,109	3,092

UNICHEMLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-251	-42	-33	-158	-117	-42	72	53
Cash from Investing Activity	-323	-36	-73	104	241	60	-176	210
Cash from Financing Activity	-45	-21	-45	96	-62	-48	38	-71
Net Cash Flow	-619	-98	-150	42	62	-30	-65	192
Free Cash Flow	-440	-419	-318	-285	-153	-53	-38	216
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	472%	50%	-34%	375%	126%	-81%	29%	99%

UNICHEMLAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%
FIIs	1.05%	0.98%	0.98%	0.99%	0.99%	1.00%	0.90%	2.70%
DIIs	11.63%	11.32%	10.92%	10.74%	10.73%	10.63%	10.46%	9.40%
Public	17.11%	17.47%	17.88%	18.04%	18.05%	18.14%	18.41%	17.67%
No. of Shareholders	21,472	21,621	23,010	23,577	23,267	23,386	25,347	26,164

UNICHEMLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	125	130	117	147	161	141	157	151
Inventory Days	242	301	326	438	335	264	267	325
Days Payable	170	199	159	150	170	132	120	124
Cash Conversion Cycle	197	233	284	436	325	274	305	352
Working Capital Days	222	215	208	271	254	199	202	248
ROCE %	-0%	-2%	2%	-3%	-6%	-1%	7%	-0%

UNICHEMLABUpdated 18 Oct 2026, 14:11

Unichem Laboratories Ltd

UNICHEMLABUpdated 18 Oct 2026, 14:11

Market Cap

₹3,595Cr.

Current Price

₹511

High / Low

₹687/278

ROE-0.61%

ROCE-0.13%

Book Value₹373

Face Value₹2.00

Dividend Yield0.00%

About

Unichem Laboratories Ltd is involved in pharmaceuticalsin Generics, APIs and Contract Manufacturing (CMO) areas.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	346.67	2.48	338.36	5.83	27.36	-15.7	0	-15.7	-2.23
Sep 2023	333.83	3.82	341.14	7.58	27.26	-30.81	0	-30.81	-4.38
Dec 2023	362.43	2.36	343.11	77.95	25.61	69.3	0	69.3	9.84
Mar 2024	399.24	1.76	368.65	-118.58	25.22	-114.97	0	-114.97	-16.33
Jun 2024	389.75	1.38	349.56	8.77	26.1	21.48	0	21.48	3.05
Sep 2024	436.88	1.82	372.38	7.08	26.39	43.37	0	43.37	6.16
Dec 2024	447.83	2.89	373.62	18.93	28.45	61.8	24.13	46.89	6.66
Mar 2025	461.24	1.53	386.26	10.05	27.47	56.03	8.58	51.22	7.27
Jun 2025	384.25	1.93	358.51	4.25	29.93	-1.87	-1.07	-1.85	-0.26
Sep 2025	356.9	3.68	349.2	-11.74	30.11	-37.83	5.55	-39.93	-5.67
Dec 2025	314.9	2.1	313.51	290.55	30.02	259.82	16.82	216.11	30.69
Mar 2026	356.24	4.09	343.75	9.86	28.97	-10.71	43.7	-15.39	-2.19
Jun 2026	366.27	1.29	345.63	16.72	28.69	7.38	25.07	5.53	0.79

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	1091	2	989	20	38	82	21	64	7.09
Mar 2016	1221	2	1078	19	35	124	19	100	11.06
Mar 2017	576	2	813	366	39	87	-19	104	11.43
Mar 2018	666	3	798	2737	45	2556	0	2557	363.48
Mar 2019	968	1	1019	94	62	-20	-144	9	1.25
Mar 2020	904	1	994	98	71	-64	-12	-56	-8
Mar 2021	1124	1	1028	47	76	66	18	54	7.68
Mar 2022	943	2	986	42	83	-87	-36	-55	-7.87
Mar 2023	1072	9	1165	-71	106	-279	7	-300	-42.57
Mar 2024	1442	10	1391	-27	105	-92	0	-92	-13.09
Mar 2025	1736	8	1482	45	108	183	11	163	23.15
Mar 2026	1412	12	1359	287	119	209	24	159	22.57
TTM	1394	11	1352	305	118	219	—	166	23.62

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	70.22%
FIIs	2.7%
DIIs	9.4%
Public	17.67%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	70.22%	0.84%	10.46%	18.47%
Mar 2024	70.22%	0.9%	11.26%	17.63%
Jun 2024	70.22%	0.89%	11.57%	17.32%
Sep 2024	70.22%	0.94%	11.65%	17.17%
Dec 2024	70.22%	1.05%	11.63%	17.11%
Mar 2025	70.22%	0.98%	11.32%	17.47%
Jun 2025	70.22%	0.98%	10.92%	17.88%
Sep 2025	70.22%	0.99%	10.74%	18.04%
Dec 2025	70.22%	0.99%	10.73%	18.05%
Mar 2026	70.22%	1%	10.63%	18.14%
Jun 2026	70.22%	0.9%	10.46%	18.41%
Sep 2026	70.22%	2.7%	9.4%	17.67%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	18	929	0	274	1222	396	119	153	555	1222
Mar 2016	18	1009	8	306	1342	381	233	111	617	1342
Mar 2017	18	1113	1	371	1503	468	247	89	698	1503
Mar 2018	14	2748	0	346	3108	555	236	979	1338	3108
Mar 2019	14	2718	0	298	3030	789	90	1042	1109	3030
Mar 2020	14	2633	17	361	3025	829	331	668	1197	3025
Mar 2021	14	2683	1	420	3119	850	568	520	1181	3119
Mar 2022	14	2658	132	318	3122	963	494	390	1275	3122
Mar 2023	14	2370	108	394	2886	1236	148	41	1462	2886
Mar 2024	14	2281	70	477	2842	1165	122	44	1510	2842
Mar 2025	14	2446	123	527	3109	1275	31	46	1758	3109
Mar 2026	14	2613	64	401	3092	1189	100	47	1755	3092

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	88	-62	-47	-21
Mar 2016	117	-87	-39	-9
Mar 2017	141	-132	-9	0
Mar 2018	-66	1648	-930	653
Mar 2019	-251	-323	-45	-619
Mar 2020	-42	-36	-21	-98
Mar 2021	-33	-73	-45	-150
Mar 2022	-158	104	96	42
Mar 2023	-117	241	-62	62
Mar 2024	-42	60	-48	-30
Mar 2025	72	-176	38	-65
Mar 2026	53	210	-71	192

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	69	79	188	127	125	130	117	147	161	141	157	151
Inventory Days	159	162	371	216	242	301	326	438	335	264	267	325
Days Payable	122	153	334	220	170	199	159	150	170	132	120	124
Cash Conversion Cycle	106	88	225	123	197	233	284	436	325	274	305	352
Working Capital Days	95	98	233	190	222	215	208	271	254	199	202	248
ROCE %	9%	13%	-8%	132%	-0%	-2%	2%	-3%	-6%	-1%	7%	-0%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of UNICHEM LABORATORIES LTD (UNICHEMLAB)?

The reported market capitalisation for UNICHEM LABORATORIES LTD (UNICHEMLAB) is ₹3,595Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of UNICHEMLAB?

The current price shown for UNICHEM LABORATORIES LTD (UNICHEMLAB) on Fincrux is ₹511 with a 52-week high/low of ₹687/278.

What were UNICHEMLAB latest quarterly results?

For Jun 2026, UNICHEM LABORATORIES LTD (UNICHEMLAB) reported sales ₹366.27 Cr and net profit ₹5.53 Cr (figures in ₹ crore unless noted).

What are UNICHEMLAB annual sales and net profit?

For TTM, UNICHEM LABORATORIES LTD (UNICHEMLAB) shows sales of ₹1,394 Cr and net profit of ₹166 Cr on the Fincrux profit & loss statement.

Who owns UNICHEM LABORATORIES LTD (UNICHEMLAB)?

Latest shareholding for UNICHEM LABORATORIES LTD (UNICHEMLAB) on Fincrux: Promoters 70.22% (Sep 2026), FIIs 2.70% (Sep 2026), DIIs 9.40% (Sep 2026), Public 17.67% (Sep 2026), No. of Shareholders 26,164% (Sep 2026).

Where can I find UNICHEM LABORATORIES LTD (UNICHEMLAB) financials?

UNICHEM LABORATORIES LTD (UNICHEMLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show UNICHEMLAB balance sheet and cash flow?

Yes. The UNICHEM LABORATORIES LTD (UNICHEMLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 14:11